Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024
Reading Time: 3 minutes Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough IND-enabling preclinical data on its drug candidate 177Lu-AKIR001 and the design of its first-in-human clinical trial at the Targeted Radiopharmaceuticals Summit Europe 2024 in Amsterdam, December 3-5. The data
Jetpak Top Holding AB (publ):Interim report 1 January – 30 September 2024
Reading Time: 5 minutes Third quarter: 1 July – 30 September June 2024 Net revenue increased by 11,7 % to 308 858 (276 583) TSEK Organic growth amounted to 1,7 % (-13,5 %) Gross margin amounted to 28,8 % (29,4 %) Adjusted EBITA amounted to
PUMA Signs Blockbuster Long-Term Partnership With the Portuguese Football Federation
Reading Time: 3 minutes Herzogenaurach, Germany: Sports company PUMA has signed a long-term agreement with the Portuguese Football Federation (FPF), one of the world’s most popular national teams. Starting in 2025, PUMA will equip all male, female and youth teams as well as the federation’s
Keturah Announces Campaign for Its Developments, Introduces 5-Year Post-Handover Plan
Reading Time: 2 minutes Dubai, United Arab Emirates: Keturah, the revolutionary global luxury wellbeing real estate and hospitality concept has announced the launch of a sales campaign for The Ritz-Carlton Residences, Dubai, Creekside—part of the Keturah Resort—and Keturah Reserve which runs until 30 December.
Why Homeowners Are Choosing Improving Over Moving
Reading Time: 4 minutes The traditional dream of moving to achieve your dream home goals has lost its lustre in recent years. Instead, many homeowners are now opting to invest in their existing properties in an effort to transform their current spaces into their
Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (26.11.2024)
Reading Time: 2 minutes Kesko Corporation has on 27 November 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 26 November 2024, BlackRock, Inc.’s holding in Kesko Corporation exceeded the
Leqembi[®] launched in South Korea
Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult
The Psychology of Online Lottery Bonuses: Insights from LottoRanker
Reading Time: 2 minutes Stockholm, Sweden – November 2024 — LottoRanker, a trusted authority in the world of online lottery, announces its latest exploration into the psychology behind online lottery bonuses and why they resonate with players. As the digital landscape of lottery gaming continues to
#24-407 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
#24-408 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market